STAT Plus: An Indian drug maker is slammed by FDA for tossing ‘cartloads of trash bags’ filled with documents
Amid global anxiety over the novel coronavirus, a newly issued warning letter by the Food and Drug Administration serves as a reminder that quality manufacturing needs to remain a priority.
Consider the March 17 missive sent to Windlas Healthcare, which formulates finished medicines for some of the world’s largest drug makers. The company committed several serious infractions that alarmed the agency following an August 2019 inspection of manufacturing facilities in northern India.
Continue to STAT Plus to read the full story…
